VIMOVO

Country: Израел

Језик: Енглески

Извор: Ministry of Health

Активни састојак:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Доступно од:

ASTRA ZENECA ISRAEL LTD

АТЦ код:

G02CC02

Фармацеутски облик:

TABLETS MODIFIED RELEASE

Пут администрације:

PER OS

Произведен од:

ASTRA ZENECA AB., SWEDEN

Терапеутска група:

NAPROXEN

Терапеутске индикације:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Датум одобрења:

2011-12-01